Circulating biomarkers as predictors of gender-specific response to Immune Checkpoint Inhibitors in melanoma and non-small-cell lung cancer patients

Circulating biomarkers as predictors of gender-specific response to Immune Checkpoint Inhibitors in melanoma and non-small-cell lung cancer patients

Tipologia

Ricerca di base/clinica

Stato

aperto

Copertura

Nazionale

Ruolo dell'Istituto

Capofila

Ente finanziatore

Ministero della Salute

Anno di finanziamento

2020

Principal Investigator

Dott.ssa Vanna Chiarion Sileni
Scroll to Top